Magnifying Glass

Showing 5 results for “Christina Klemm | Expert Analysis”

Search Results

Understanding Morphine Equivalent Dose (MED) and Why It Matters in Claims Management

By: Christina Klemm, Pharm.D., BCACP, Clinical Operations, Enlyte Morphine Equivalent Dose (MED) is a standardized way to estimate a person's total opioid exposure over a 24-hour period. Because different opioid medications have varying potencies, a common […]

FDA Approves Journavx as Safer Alternative to Opioids for Acute Pain Relief

By: Christina Klemm, Pharm.D., BCACP, Clinical Pharmacist, Enlyte The U.S. Food and Drug Administration (FDA) recently approved Journavx (suzetrigine), a novel non-opioid medication developed by Vertex Pharmaceuticals for the treatment of moderate to severe acute pain in […]

The Role of Ketamine in Pain Management for Workers’ Compensation

By: Christina Klemm, Pharm.D., BCACP, Clinical Pharmacist, Enlyte Developed in the 1960s as an anesthetic, ketamine quickly became a staple in emergency and battlefield medicine. Its ability to act as a powerful, rapid-acting anesthetic was […]

Who Should Receive Urine Drug Testing and How Often?

By: Christina Klemm, Pharm.D., BCACP, Clinical Pharmacist, Enlyte Pharmacy Solutions Urine drug testing (UDT) plays an important role in workers’ compensation, serving as an essential tool for pharmacy benefit managers (PBMs) to ensure safe and […]

Medications to Address Opioid Addiction in Workers’ Comp

By Christina Klemm, Pharm.D., BCACP, Clinical Pharmacist Recently the U.S. Food and Drug Administration (FDA) approved an over-the-counter (OTC) naloxone hydrochloride nasal spray product for treating opioid overdose. For the first time, medication to reverse […]